BRUKER CORP (BRKR) Stock Fundamental Analysis
USA - NASDAQ:BRKR - US1167941087 - Common Stock
32.49 USD
+1.61 (+5.21%)
32.49 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to BRKR. BRKR was compared to 56 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
In the past 5 years BRKR has always been profitable.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 1.26%, BRKR is doing good in the industry, outperforming 66.07% of the companies in the same industry.
The Return On Equity of BRKR (4.41%) is better than 69.64% of its industry peers.
BRKR has a Return On Invested Capital of 4.48%. This is in the better half of the industry: BRKR outperforms 67.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is significantly below the industry average of 14.87%.
The last Return On Invested Capital (4.48%) for BRKR is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
Looking at the Profit Margin, with a value of 2.31%, BRKR is in the better half of the industry, outperforming 66.07% of the companies in the same industry.
In the last couple of years the Profit Margin of BRKR has declined.
BRKR has a better Operating Margin (9.69%) than 67.86% of its industry peers.
BRKR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 48.54%, BRKR is in line with its industry, outperforming 51.79% of the companies in the same industry.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
BRKR has an Altman-Z score of 2.06. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.06) which is in line with its industry peers.
BRKR has a debt to FCF ratio of 49.40. This is a negative value and a sign of low solvency as BRKR would need 49.40 years to pay back of all of its debts.
BRKR's Debt to FCF ratio of 49.40 is in line compared to the rest of the industry. BRKR outperforms 50.00% of its industry peers.
BRKR has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
BRKR has a Debt to Equity ratio of 1.32. This is amonst the worse of the industry: BRKR underperforms 80.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.48
WACC9.38%
2.3 Liquidity
BRKR has a Current Ratio of 1.61. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.61, BRKR is not doing good in the industry: 69.64% of the companies in the same industry are doing better.
A Quick Ratio of 0.68 indicates that BRKR may have some problems paying its short term obligations.
BRKR's Quick ratio of 0.68 is on the low side compared to the rest of the industry. BRKR is outperformed by 89.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.99%.
Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
The Revenue has grown by 10.36% in the past year. This is quite good.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
BRKR is valuated correctly with a Price/Earnings ratio of 15.11.
Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 91.07% of the companies listed in the same industry.
BRKR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.65, which indicates a correct valuation of BRKR.
92.86% of the companies in the same industry are more expensive than BRKR, based on the Price/Forward Earnings ratio.
BRKR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.11 | ||
| Fwd PE | 13.65 |
4.2 Price Multiples
BRKR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRKR is cheaper than 92.86% of the companies in the same industry.
BRKR's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 99.99 | ||
| EV/EBITDA | 13.37 |
4.3 Compensation for Growth
BRKR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.69
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
BRKR has a yearly dividend return of 0.62%, which is pretty low.
In the last 3 months the price of BRKR has falen by -23.46%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.57. BRKR pays more dividend than 92.86% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
BRKR pays out 38.32% of its income as dividend. This is a sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.32%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
32.49
+1.61 (+5.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner Change3.05%
Ins Owners26.98%
Ins Owner Change0.2%
Market Cap4.93B
Analysts76.19
Price Target45.76 (40.84%)
Short Float %11.81%
Short Ratio2.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)-0.37%
PT rev (3m)-16.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.52%
EPS NY rev (1m)-2.29%
EPS NY rev (3m)-19.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.94%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-1.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.11 | ||
| Fwd PE | 13.65 | ||
| P/S | 1.43 | ||
| P/FCF | 99.99 | ||
| P/OCF | 29.71 | ||
| P/B | 2.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.37 |
EPS(TTM)2.15
EY6.62%
EPS(NY)2.38
Fwd EY7.33%
FCF(TTM)0.32
FCFY1%
OCF(TTM)1.09
OCFY3.37%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)1.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 2.06 |
F-Score5
WACC9.38%
ROIC/WACC0.48
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.69%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%